Skip to main content
. Author manuscript; available in PMC: 2016 Oct 24.
Published in final edited form as: Circulation. 2008 May 5;117(19):2484–2491. doi: 10.1161/CIRCULATIONAHA.107.736108

Table 2.

Adjusted Associations of Leg Symptom Categories With Peripheral Nerve Function in Persons With PAD*

Always Asymptomatic (n=67) Sometimes Asymptomatic (n=29) Pain on Exertion and Rest (n=95) Pain/Carry on (n=42) IC (n=194)
Peroneal NCV m/s 33.07 41.17 37.08 41.15 40.32
Peroneal nerve amplitude, mV 1.92 3.44 2.68 2.78 3.10
Peroneal latency, ms 5.00 4.97 5.02 4.84 4.93
Sural NCV, m/s 40.67 40.13 41.80 42.18 43.08
Sural amplitude, mV 3.29 4.28 4.59 6.76 5.52
Sural latency, ms 5.49§ 3.56 3.66 3.18 3.33
Ulnar motor NCV, m/s 49.84 50.35 50.28 51.77 50.62
Ulnar motor nerve amplitude, mV 8.42 8.71 8.86 9.14 8.92
Ulnar motor nerve latency, ms 2.89 2.82 2.82 2.74 2.80

Analyses include participants with 0 values for NCV. When analyses were repeated excluding participants with 0 values for NCV differences in peroneal NCV between participants with IC and those who were always asymptomatic were no longer statistically significant.

*

Analyses adjust for age, sex, race, BMI, ABI, comorbidities, recruitment cohort, cigarette smoking, height, lower extremity revascularization, and alcohol use.

P= 0.0002

P= 0.0051

§

P= 0.0056 for pairwise comparisons of always asymptomatic PAD participants vs IC.